Table 1.
Correlation matrix of striatal DAT and post-treatment barrier performance
Post-Tx barriers | Post-Tx 25 cm barrier | Post-Tx 30 cm barrier | NAc DAT | CP Subregion DAT | ||||
---|---|---|---|---|---|---|---|---|
dmCP | dlCP | vmCP | vlCP | |||||
Post-Tx barriers | 1.00 | 0.25*** | ns | ns | ns | ns | ||
Post-Tx 25 cm barrier | 1.00 | 0.61*** | ns | ns | ns | ns | ns | |
Post-Tx 25 cm barrier | 1.00 | 0.36* | ns | ns | ns | ns |
Scores are reported as r values showing levels of DAT binding in regions of the CP and NAc and their association with post-treatment performance over barriers
Post-Tx barriers post-treatment performance over all barrier heights, post-Tx 25 cm barrier post-treatment performance over the 25-cm barrier, post-Tx 30 cm barrier post-treatment performance over the 30-cm barrier, DAT dopamine transporter, CP caudate putamen, dmCP dorsomedial caudate putamen, dlCP dorsolateral caudate putamen, vmCP ventromedial caudate putamen, vlCP ventrolateral caudate putamen
p<0.05;
p<0.01;
p<0.001